$Recursion Pharmaceuticals(RXRX.US)

Held for almost a year, ups and downs, but based on the principle of understanding, the cost has been reduced to a very low level, the margin of safety is sufficient, just waiting for the "empirical" logic loop of AI pharmaceutical R&D to be validated, be a friend of time!

The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.